Nexthera Capital as of Sept. 30, 2017
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 37 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 33.4 | $130M | 1.5M | 86.57 | |
| Seattle Genetics | 5.2 | $20M | 373k | 54.41 | |
| Clovis Oncology | 4.7 | $18M | 220k | 82.40 | |
| Teva Pharmaceutical Industries (TEVA) | 4.5 | $18M | 1.0M | 17.60 | |
| GlaxoSmithKline | 3.7 | $15M | 358k | 40.60 | |
| Sangamo Biosciences (SGMO) | 3.0 | $12M | 781k | 15.00 | |
| Fibrogen | 3.0 | $12M | 217k | 53.80 | |
| BioMarin Pharmaceutical (BMRN) | 2.9 | $11M | 120k | 93.07 | |
| Immunomedics | 2.9 | $11M | 792k | 13.98 | |
| Aclaris Therapeutics (ACRS) | 2.8 | $11M | 416k | 25.81 | |
| Shire | 2.7 | $11M | 70k | 153.14 | |
| Dova Pharmaceuticals | 2.7 | $11M | 438k | 24.28 | |
| Alnylam Pharmaceuticals (ALNY) | 2.4 | $9.4M | 80k | 117.48 | |
| Achaogen | 2.4 | $9.2M | 578k | 15.95 | |
| Alexion Pharmaceuticals | 2.2 | $8.7M | 62k | 140.29 | |
| Global Blood Therapeutics In | 2.2 | $8.4M | 270k | 31.05 | |
| Impax Laboratories | 2.1 | $8.2M | 402k | 20.30 | |
| Array BioPharma | 1.9 | $7.6M | 615k | 12.30 | |
| Flexion Therapeutics | 1.7 | $6.6M | 271k | 24.18 | |
| Tesaro | 1.7 | $6.5M | 50k | 129.10 | |
| Paratek Pharmaceuticals | 1.6 | $6.1M | 242k | 25.10 | |
| Supernus Pharmaceuticals (SUPN) | 1.4 | $5.3M | 132k | 40.00 | |
| Abeona Therapeutics | 1.3 | $5.1M | 300k | 17.05 | |
| Insmed (INSM) | 1.2 | $4.5M | 144k | 31.21 | |
| Glycomimetics | 1.2 | $4.5M | 321k | 13.99 | |
| Minerva Neurosciences | 1.1 | $4.1M | 537k | 7.60 | |
| Kura Oncology (KURA) | 1.0 | $3.9M | 259k | 14.95 | |
| Ignyta | 0.9 | $3.5M | 286k | 12.35 | |
| Marinus Pharmaceuticals | 0.9 | $3.5M | 600k | 5.87 | |
| Intec Pharma | 0.6 | $2.5M | 276k | 8.95 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $1.3M | 29k | 45.00 | |
| Steadymed | 0.2 | $867k | 259k | 3.35 | |
| Zosano Pharma | 0.1 | $308k | 376k | 0.82 | |
| Axovant Sciences | 0.1 | $275k | 40k | 6.88 | |
| Vistagen Therapeutics | 0.1 | $221k | 138k | 1.60 | |
| AVEO Pharmaceuticals | 0.1 | $190k | 52k | 3.65 | |
| Cymabay Therapeutics | 0.0 | $121k | 15k | 8.07 |
